Evidence map›Paper›PMID 31801066›Full record

ArticleCell reports2019

Group A Streptococcal S Protein Utilizes Red Blood Cells as Immune Camouflage and Is a Critical Determinant for Immune Evasion.

Igor H Wierzbicki, Anaamika Campeau, Diana Dehaini, Maya Holay, Xiaoli Wei, Trever Greene, Man Ying, Jenna S Sands, Anne Lamsa, Elina Zuniga and 5 more

Abstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Surface-Attached Model Lipid Membranes Derived from Human Red Blood Cells.Langmuir : the ACS journal of surfaces and colloids · 2026
    Article
  9. [Research progress on toxic shock syndrome due to group AZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. ThemBio · 2025
    Article
  14. Microbial genomics · 2025
    Article
  15. Article
  16. Article
  17. The burden of group AiScience · 2025
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Igor H WierzbickiDepartment of Pharmacology and the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA.
Anaamika CampeauDepartment of Pharmacology and the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA.
Diana DehainiDepartment of NanoEngineering and Chemical Engineering Program, University of California, San Diego, La Jolla, CA 92093, USA.
Maya HolayDepartment of NanoEngineering and Chemical Engineering Program, University of California, San Diego, La Jolla, CA 92093, USA.
Xiaoli WeiDepartment of NanoEngineering and Chemical Engineering Program, University of California, San Diego, La Jolla, CA 92093, USA.
Trever GreeneDepartment of Biological Sciences, University of California, San Diego, La Jolla, CA 92037, USA.
Man YingDepartment of NanoEngineering and Chemical Engineering Program, University of California, San Diego, La Jolla, CA 92093, USA.
Jenna S SandsDepartment of Microbiology and Immunology, Division of Infectious Diseases, and Antimicrobial Resistance Center, Emory University, Atlanta, GA 30322, USA.
Anne LamsaDepartment of Biology, University of California, San Diego, La Jolla, CA 92093, USA.
Elina ZunigaDepartment of Biological Sciences, University of California, San Diego, La Jolla, CA 92037, USA.
Kit PoglianoDepartment of Biology, University of California, San Diego, La Jolla, CA 92093, USA.
Ronnie H FangDepartment of NanoEngineering and Chemical Engineering Program, University of California, San Diego, La Jolla, CA 92093, USA.
Christopher N LaRockDepartment of Microbiology and Immunology, Division of Infectious Diseases, and Antimicrobial Resistance Center, Emory University, Atlanta, GA 30322, USA.
Liangfang ZhangDepartment of NanoEngineering and Chemical Engineering Program, University of California, San Diego, La Jolla, CA 92093, USA.
David J GonzalezDepartment of Pharmacology and the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: djgonzalez@ucsd.edu.

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Identification of natural products targeting new pathways in bacteriaR01AI113295 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI POGLIANO, JOSEPH A, POGLIANO, KIT J · 2014 to 2018
$3.3M
INTERDISCIPLINARY PROGRAM IN BACTERIAL PATHOGENESIST32AI055396 · NIAID · UNIVERSITY OF WASHINGTON · PI FANG, FERRIC C · 2003 to 2019
$2.8M
Biomimetic Virulomics for Capture and Identification of Cell-Type Specific EffectorProteinsR21AI149090 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GONZALEZ, DAVID J · 2020 to 2021
$433k
IL-1 regulation of group A Streptococcus infectionK22AI130223 · NIAID · EMORY UNIVERSITY · PI LAROCK, CHRISTOPHER N · 2018 to 2019
$269k
NIAID NIH HHS K22 AI130223NIAID NIH HHS R01 AI113295NIAID NIH HHS R21 AI149090NIAID NIH HHS T32 AI055396NIGMS NIH HHS T32 GM007752
6 · The paper itself

Abstract

Group A Streptococcus (GAS) is a human-specific pathogen that evades the host immune response through the elaboration of multiple virulence factors. Although many of these factors have been studied, numerous proteins encoded by the GAS genome are of unknown function. Herein, we characterize a biomimetic red blood cell (RBC)-captured protein of unknown function-annotated subsequently as S protein-in GAS pathophysiology. S protein maintains the hydrophobic properties of GAS, and its absence reduces survival in human blood. S protein facilitates GAS coating with lysed RBCs to promote molecular mimicry, which increases virulence in vitro and in vivo. Proteomic profiling reveals that the removal of S protein from GAS alters cellular and extracellular protein landscapes and is accompanied by a decrease in the abundance of several key GAS virulence determinants. In vivo, the absence of S protein results in a striking attenuation of virulence and promotes a robust immune response and immunological memory.

Indexed as

AnimalsBacterial ProteinsCell LineErythrocytesGene Expression ProfilingGene Expression Regulation, BacterialHost-Pathogen InteractionsHumansImmune EvasionMiceMice, Inbred C57BLMice, Inbred ICRProteomicsStreptococcal InfectionsStreptococcusTHP-1 CellsBacterial ProteinsVirulence FactorsBiomimetic Virulomicsgroup A Streptococcusmultiplexed proteomicsS proteinSPy_0802S. pyogenessystemic infectiontandem mass tagsvirulence

Identifiers

PMID31801066
PMCPMC6951797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.